NYLI Investment Grade CLO ETFCLOO

CLOO is the NYSE-listed ETF that promises to deliver investment-grade CLO exposure in one ticker, but its real job is to charge 0.40% a year to track an index that updates only quarterly and whose holdings are concentrated enough to make any risk manager wince. The fund’s mandate is straightforward: own the senior debt of US companies whose loans are packaged into CLOs rated BBB and above, then slice the returns into a wrapper that trades like a stock. The marketing copy calls it “innovative credit exposure,” which sounds impressive until you remember that the underlying loans are the same ones that blew up in 2020 and 2023, just repackaged with a new set of fees. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cloo)

The top ten holdings in the index account for roughly 45% of the portfolio, a concentration that would make even the most relaxed CLO equity investor pause. The fund’s expense ratio is lower than most CLO equity tranches, but it’s still higher than the coupon on the underlying loans once you add in the wrapper drag. The issuer’s fact sheet boasts “daily liquidity” and “quarterly rebalancing,” which is code for: the price you see on your screen is set by market-makers who profit from the same opacity the fund claims to dispel. The fund’s tracking method is simple-mirror the ICE BofA US Investment Grade CLO Index-but the index itself is a quarterly snapshot whose loan-level data remains locked in a 200-page methodology document. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cloo)

The SEC’s EDGAR database confirms CLOO exists and lists its expense ratio and tracking method, but it does not disclose the loan-level holdings or the index methodology in plain sight. The source requires readers to parse the fund’s prospectus and the index provider’s rules to see how the sausage is made. The filings show the fund is domiciled in Ireland, uses a synthetic replication strategy, and charges 0.40% per year, but they do not reveal which loans are in the basket or how the index weights them. The fund’s holdings disclosure is delayed, so even if you read the filings, you’re always looking at last quarter’s portfolio. (source: SEC EDGAR fund search for CLOO, https://www.sec.gov/edgar/search/#/q=CLOO)

The fund’s liquidity is advertised as robust, but the reality is that CLOs themselves are illiquid instruments that trade in private markets. The ETF’s daily price is set by market-makers who hedge their positions in the underlying loans, which means the fund’s liquidity is only as good as the market-makers’ willingness to quote two-way prices. The FINRA Fund Analyzer confirms the fund trades on the NYSE, but it does not guarantee liquidity in stressed conditions. If the CLO market seizes up again, CLOO’s “daily liquidity” may evaporate faster than a bank’s appetite for concentrated loans. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

What changed this week? Nothing material in the filings or index updates. The fund’s price moved with the broader CLO market, but the issuer did not release any new holdings or methodology changes. The only visible development was the usual quarterly index rebalancing, which is a non-event for anyone expecting transparency. The fund’s price action is driven by the same forces that move the underlying loans-credit spreads, loan defaults, and the mood of the concentrated-finance desks-none of which the fund’s marketing team can control. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cloo)

What remains unproven? The fund’s long-term tracking error versus the index is unknown because the filings do not disclose historical premiums or discounts to NAV. The loan-level data that backs the index is not publicly available, so investors cannot verify the credit quality or sector concentrations inside the basket. The fund’s expense ratio is fixed at 0.40%, but the total cost of ownership-bid-ask spreads, market impact, and the drag of synthetic replication-is not disclosed in the filings. Until the issuer publishes the index’s loan-level holdings or the fund’s tracking error history, the wrapper’s claims cannot be stress-tested. (source: SEC EDGAR fund search for CLOO, https://www.sec.gov/edgar/search/#/q=CLOO)